Mono Pharmacare Limited — Board Meeting, 31-05-2025: Outcome of Board Meeting

Mono Pharmacare Limited has announced a board meeting to approve the financial results for the quarter and half-year. The consolidated audited results for the year ending March 2025 show stable performance, driven by its two subsidiaries contributing significant revenues and profits. The company has fully deployed its IPO proceeds of ₹14.84 Cr, mainly towards working capital, corporate purposes, and issue expenses. The audit report affirms the company’s solid financial health with no concerns on its continuity.